Why tPA is an unreliable stroke treatment
The only FDA-approved drug for treating ischemic stroke is intravenous tissue Plasminogen Activator (tPA). The disadvantages of tPA are most apparent in the narrow time frame in which it must be administered, even though it is an effective treatment for stroke when used correctly. What is tPA? TPA is the only ischemic stroke treatment available…
Read More